The Nexus of Stemness, Telomere Stability, and Metabolic Reprogramming in Glioblastoma: Foundations of Tumor

Ji-Yong Sung1, Kihwan Hwang1

  • 1Department of Neurosurgery Seoul National University Bundang Hospital, Seoul National University, College of Medicine Seongnam Republic of Korea.

Medcomm
|April 3, 2026
PubMed

Insights

Glioblastoma stemness, telomere maintenance, and metabolism form a self-reinforcing system driving tumor recurrence. Targeting this "Triadic Nexus" offers new therapeutic strategies for brain tumors.

Area of Science:

  • Neuro-oncology
  • Cancer Stem Cell Biology
  • Molecular Oncology

Background:

  • Glioblastoma (GBM) is an aggressive brain tumor characterized by therapy resistance and inevitable recurrence.
  • Glioma stem-like cells (GSCs) are central to GBM's persistence, exhibiting self-renewal, plasticity, and stress resistance.
  • The molecular underpinnings of GSC long-term tumor-propagating capacity are not fully understood.

Purpose of the Study:

  • To propose the
  • Triadic Nexus
  • framework integrating GSC stemness, telomere maintenance, and metabolic reprogramming.
  • To synthesize recent advances in understanding GBM recurrence and therapy resistance.

Main Methods:

  • Review of current literature on GSC biology, telomere maintenance (telomerase vs. ALT), and metabolic reprogramming in GBM.
  • Integration of findings from single-cell, spatial, and multi-omics studies.
  • Conceptual framework development based on interdependent regulatory systems.

Main Results:

  • GSC stemness, telomere maintenance, and metabolic reprogramming function as a self-reinforcing regulatory system (the Triadic Nexus).
  • Telomere maintenance pathways (telomerase vs. ALT) differentially impact genomic stability, immune signaling, and metabolism.
  • Metabolic plasticity influences GSC stemness and telomere stress responses, collectively driving therapy resistance and recurrence.

Conclusions:

  • The Triadic Nexus provides a systems-level framework for understanding GBM persistence.
  • Targeting this interconnected system offers potential for novel combinatorial therapies and biomarker development.
  • Understanding telomere and metabolic signatures can guide patient stratification and next-generation therapeutic interventions for glioblastoma.

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.6K
Replicative Cell Senescence02:15

Replicative Cell Senescence

3.5K
Telomeres and Telomerase02:41

Telomeres and Telomerase

8.1K
Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
28.6K
Maintenance of the ES Cell State01:14

Maintenance of the ES Cell State

The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
2.8K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.4K